Compass Therapeutics Balance Sheet (2018-2026)

Reported Financials

Compass Therapeutics Quarterly Balance Sheet

Periods 35 quarters

Latest Sep 2026

Compass Therapeutics reported total assets of $174.50M and total liabilities of $31.93M for the quarter ended Sep 2026, down 24.5% year over year. This balance sheet covers 35 quarters of results from Mar 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	144.51M	136.40M	26.24M	16.48M	34.95M	27.03M	19.28M	30.43M	24.23M	43.48M	19.40M	37.37M	44.05M	41.62M	23.42M	46.78M	31.21M	55.74M	36.02M	42.04M
Short-term InvestmentsInvestments (Current)			105.78M	104.12M	151.66M	148.14M	149.47M	133.28M	128.23M	132.58M	126.82M	98.60M	83.24M	71.59M	78.09M	173.68M	178.26M	139.52M	144.43M	121.59M
Cash & Current Investments	144.51M	136.40M	132.02M	120.60M	186.61M	175.17M	168.75M	163.70M	152.46M	176.06M	146.23M	135.97M	127.29M	113.20M	101.52M	220.46M	209.47M	195.26M	180.45M	163.63M
Prepaid Assets	2.59M	3.90M	2.53M	1.95M	8.18M	8.43M	6.52M	2.88M	1.42M	2.36M	7.32M	5.74M	6.03M	11.51M	5.25M	1.23M	0.91M	1.00M	1.01M	2.44M
Current Assets	147.11M	140.28M	134.55M	122.55M	194.79M	183.60M	175.27M	166.58M	153.88M	158.61M	153.55M	141.14M	132.75M	124.15M	106.20M	221.12M	209.82M	195.69M	180.89M	165.50M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	2.24M	2.14M	1.85M	1.71M	1.57M	1.37M	1.20M	1.05M	0.90M	0.74M	0.59M	0.49M	0.35M	0.10M	0.13M	0.12M	0.10M	0.17M	0.32M	0.40M
Long-Term Investments
Intangibles					0.36M				0.36M
Goodwill & Intangibles					0.36M				0.36M
Long-Term Deferred Tax	1.17M				0.81M				0.49M				1.90M				2.56M
Other Non-Current Assets	0.32M	0.32M	0.32M	0.32M	0.32M	0.32M	0.32M	0.32M	0.32M	0.32M	0.32M	0.57M	0.57M	0.57M	0.57M	0.57M	0.57M	0.57M	0.57M	0.57M
Non-Current Assets	6.65M	6.28M	5.71M	5.28M	4.85M	4.37M	3.91M	3.45M	2.99M	2.53M	2.07M	8.01M	7.65M	7.31M	10.50M	10.14M	9.77M	9.48M	9.28M	9.00M
Assets	153.76M	146.56M	140.26M	127.84M	199.65M	187.98M	179.18M	170.04M	156.88M	161.14M	155.61M	149.15M	140.40M	131.45M	116.70M	231.26M	219.59M	205.17M	190.17M	174.50M
Liabilities
Current Liabilities
Accounts Payables	0.87M	0.26M	6.53M	2.76M	3.38M	1.13M	0.72M	2.31M	4.09M	0.85M	1.19M	0.96M	2.25M	1.58M	2.60M	3.10M	1.59M	0.91M	2.91M	6.32M
Notes Payables
Payables	0.87M	0.26M	6.53M	2.76M	3.38M	1.13M	0.72M	2.31M	4.09M	0.85M	1.19M	0.96M	2.25M	1.58M	2.60M	3.10M	1.59M	0.91M	2.91M	6.32M
Accumulated Expenses	8.78M	8.05M	3.30M	5.74M	11.69M	8.94M	7.83M	5.64M	2.51M	1.82M	7.23M	2.92M	6.29M	13.21M	10.99M	8.68M	11.38M	8.00M	11.59M	16.38M
Other Accumulated Expenses	0.47M	1.47M	0.29M	0.09M	0.10M	0.14M	0.26M	0.39M	0.24M	0.28M	0.31M	0.17M	0.62M	0.27M	0.38M	0.14M	0.48M	0.71M	1.18M	1.04M
Short term Debt
Current Leases	0.99M	1.03M	1.05M	1.08M	1.10M	1.12M	1.15M	1.17M	1.20M	1.22M	1.09M	0.56M	0.34M	0.11M	0.27M	0.63M	1.00M	1.37M	1.64M	1.67M
Total Current Liabilities	10.63M	9.33M	10.88M	9.58M	16.17M	11.19M	9.70M	9.12M	7.80M	3.89M	9.51M	4.43M	8.87M	14.90M	13.86M	12.41M	13.97M	10.28M	16.13M	24.37M
Non-Current Liabilities
Non-Current Debt
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax	-0.06M												-0.06M				-0.08M
Operating Leases	3.05M	2.74M	2.44M	2.14M	1.84M	1.52M	1.20M	0.87M	0.54M	0.19M		6.32M	6.30M	6.27M	9.63M	8.83M	8.83M	8.42M	8.00M	7.56M
Total Liabilities	13.68M	12.07M	13.33M	11.72M	18.01M	12.71M	10.90M	9.99M	8.34M	4.08M	9.51M	10.75M	15.17M	21.17M	23.49M	21.65M	22.80M	18.70M	24.12M	31.93M
Shareholder's Equity
Total Debt
Common Equity	140.08M	134.49M	126.93M	116.12M	181.64M	175.27M	168.29M	160.05M	148.54M	157.06M	146.10M	138.40M	125.23M	110.28M	93.21M	209.61M	196.79M	186.47M	166.05M	142.57M
Liabilities and Shareholders Equity	153.76M	146.56M	140.26M	127.84M	199.65M	187.98M	179.18M	170.04M	156.88M	161.14M	155.61M	149.15M	140.40M	131.45M	116.70M	231.26M	219.59M	205.17M	190.17M	174.50M
Treasury Stock
Retained Earnings	-233.59M	-240.75M	-249.25M	-261.22M	-272.81M	-280.65M	-291.93M	-301.89M	-315.31M	-326.10M	-339.17M	-349.65M	-364.68M	-381.32M	-401.20M	-415.46M	-431.17M	-449.49M	-474.64M	-501.81M

Compass Therapeutics Balance Sheet API

Pull Compass Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CMPX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "CMPX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=CMPX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Compass Therapeutics CMPX Balance Sheet (2018-2026)

Compass Therapeutics Quarterly Balance Sheet

Compass Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password